Skip to content

First Trust Nasdaq Lux Digital Health Solutions ETF

EKGNasdaqD

$23.29−0.10 (−0.43%)

At close: Oct 13, 2026, 4:00 PM

Intraday session: down, 18 prints from 23.39 to 23.29. Range 23.11 to 23.43. Use the arrow keys to read each point.23.1023.2010 AM12 PM2 PM4 PM
Expense ratio
0.65%
Fund size
$9M
1Y total return
+35.4%
Yield · Last 12 months
—
Holdings
52
Avg volume · 30D
0M sh
NAV per share
$23.43
52W range
low $15.71high $24.53
Launched
Filings
SEC EDGAR

The ETF.net EKG Grade

D

Score 36 out of 100

Rank
19 of 25
Six-pillar profile for EKG. Scores out of 100: Cost 33, Risk 42, Mission 70, Tradability 38, Holdings 45, Durability 23. Strongest: Mission (70). Weakest: Durability (23). Leans toward Mission.

Score 36 of 100 falls in the D band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

Very small fund, grade capped at C.

The cap holds the Score at 40 or below, so B and A are out of reach.

The pillars earned
37
This cap took
−0
Published Score
36 Grade D
  • Cost

    The fund’s net expense ratio, ranked against its category.
    D33 out of 100
    Rank 17 of 25
  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    A70 out of 100
    Rank 9 of 11
  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    C42 out of 100
    Rank 16 of 24
  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    D38 out of 100
    Rank 15 of 25
  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    C45 out of 100
    Rank 19 of 25
  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    F23 out of 100
    Rank 23 of 25

Our read on EKG

ETF.net Research

DA ticker that spells out the mandate. EKG skips the pharma giants and tracks a Nasdaq index of health technology names: roughly 40 stocks building the digital plumbing of medicine, from diagnostics and devices to health data.

Stated mandate

The Fund seeks to track, before fees and expenses, the price and yield performance of the Nasdaq Lux Health TechTM Index.

Why people hold it

  1. 01Genuinely narrow. Roughly 40 health tech names, not a broad sector fund where a few pharma megacaps set the outcome.
  2. 02Rules-based, not a stock picker's fund. It tracks the Nasdaq Lux Health Tech Index, so holdings follow published index rules rather than manager discretion.ftportfolios.com
  3. 03Launched in 2022, so there is a real multi-year record to inspect instead of a back-test on a brand-new theme fund.

Worth knowing

  1. 010.65% a year sits above the health care sector median, and the cohort's broad index heavyweights (VHT, XLV, FHLC) charge under a tenth of a percent.
  2. 02A small fund that trades thinly. Wider bid-ask spreads are the usual trade-off versus the cohort's most heavily traded names.
  3. 03One theme, about 40 stocks, no regular distribution schedule. Single names and the health tech cycle carry the weight here.

EKG Holdings

As of Oct 12, 2026
Asset class
Stocks
Holdings
52
Top-10 weight
59%
Largest holding
NTRA9.4%

Sectors

  • Health Care92.0%
  • Technology8.0%

Geography

  • United States96.80%
  • Netherlands3.20%
The fund’s holdings, weight-ordered — page 1 of 4.
#TickerCompanyWeight %SharesMarket valueIn ETFs
001NTRANatera, Inc.9.37%2,191$878K238
002ISRGIntuitive Surgical, Inc.8.47%1,872$794K410
003VEEVVeeva Systems Inc. (Class A)7.79%2,466$730K323
004IQVIQVIA Holdings Inc.7.48%2,698$701K289
005DXCMDexCom, Inc.6.95%7,745$651K368
006ILMNIllumina, Inc.4.89%1,649$459K322
007GHGuardant Health, Inc.3.96%2,217$371K175
008RMDResMed Inc.3.60%1,466$337K319
009QGENQiagen N.v.3.20%6,609$300K50
010GMEDGlobus Medical, Inc. (Class A)3.20%4,017$300K160
011OSCROscar Health, Inc. (Class A)2.94%8,271$276K133
012TEMTempus AI, Inc. (Class A)2.82%3,722$264K107
013PODDInsulet Corporation2.81%1,945$263K217
014ALGNAlign Technology, Inc.2.68%1,760$251K227
015TWSTTwist Bioscience Corporation2.40%1,409$225K125

Showing 1–15 of 52 holdings

EKG Performance

Launched Mar 22, 2022

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

Not enough history yet.Not enough history yet.
EKG$13,536
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$12,044
Oct 10, 2025 to Oct 12, 2026. EKG $13,536. SPY $12,044. Use the arrow keys to read each point.$8,697$11,560$14,423Oct 2025Apr 2026Oct 2026

Oct 10, 2025 – Oct 12, 2026

Returns run to the Oct 12, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for EKG. Periods over one year show the average yearly return.
PeriodEKG
Year to date+23.2%
1 month+9.6%
3 months+19.5%
1 year+35.4%
3 yearsper year+21.6%
5 yearsFund is under 5 years oldper year—
10 yearsFund is under 10 years oldper year—

As of the close, with distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for EKG
YearReturn barEKG
2026 YTD+23.2%
2025+11.8%
2024+6.5%
2023−0.1%
2022−20.8%

History from Mar 24, 2022

EKG in the news

Filtered to EKG · Health Care (Broad)

EKG Dividends

This fund pays no distributions.
—Last 12 months
Payout per share
—Last 12 months

No distributions in the last 12 months.

EKG Risk

How much the fund’s monthly returns vary, scaled to a year.
23.7%
Annualised · 36 months to Sep 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
0.67
vs 3-month T-bills · to Sep 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−43.8%
54 months · trough Oct 2023
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
1.43
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

EKG Cost

Expense ratio0.65%
  • The middle half of Health Care (Broad) funds
  • Median 0.50%

16 of the 25 Health Care (Broad) funds charge less.

EKG costs $65.00 a year on $10,000. The median Health Care (Broad) fund costs $50.00.

Other funds in Health Care (Broad)